Skip to ContentSkip to Navigation
Over onsFaculty of Science and EngineeringOnderzoekGRIPNews and activitiesAgenda

Lecture Prof Glauco Souza

When:Tu 16-10-2018 11:00 - 12:00
Where:ADL 1, Building 3111.0105

Director of Global Business Development and Innovation, 3D Cell Culture Greiner Bio-One Adjunct Assistant Professor, University of Texas Health Science Center at Houston, TX USA

" Magnetic 3D Bioprinting: from Generating Spheroids to Fingerprinting Cell-Types"

Dr. Glauco R. Souza is the President, CSO, and co-founder of Nano3D Biosciences, Inc. (n3D). He is one of the co-inventors and inventor of all eleven patents related to magnetic 3D cell, including magnetic 3D bioprinting and levitation technologies. Dr. Souza is also Adjunct Assistant Professor at University of Texas Health Science Center at Houston. Prior to co-founding n3D, Dr. Souza was an Odyssey Scholar at UT MD Anderson Cancer Center. During his work at MD Anderson, he applied a multidisciplinary approach to developing nanotechnology tools for tissue targeted imaging, gene delivery, and tissue engineering. Towards the end of his Odyssey Scholarship tenure at MD Anderson, in collaboration with Rice University, the genesis of 3D cell culturing by magnetic levitation and magnetic 3D bioprinting took place. Results using these groundbreaking technologies have been reported in various high-impact scientific journals, including Nature Nanotechnology, Proceedings of the National Academy of Sciences, Nature Protocols, Biomaterials, and Nature Reviews Cancer. Now, Glauco's mission is to advance magnetic 3D cell culture into a routine laboratory tool that will measurably improve the drug discovery process, cancer research, personalized medicine, and regenerative medicine. Recently, his work was selected for the Short List of The 2017 Lush Prize for outstanding research producing an effective non-animal safety test. Dr. Souza's research has been funded by grants from National Science Foundation (NSF), National Institute of Health (NIH), Department of Defense (DOD), and others.

Host: Professor Martina Schmidt, Head Molecular Pharmacology, GRIP,